ECSP045153A - Metodo y composición para aumentar la potencia de un analgésico de narcotico. - Google Patents

Metodo y composición para aumentar la potencia de un analgésico de narcotico.

Info

Publication number
ECSP045153A
ECSP045153A EC2004005153A ECSP045153A ECSP045153A EC SP045153 A ECSP045153 A EC SP045153A EC 2004005153 A EC2004005153 A EC 2004005153A EC SP045153 A ECSP045153 A EC SP045153A EC SP045153 A ECSP045153 A EC SP045153A
Authority
EC
Ecuador
Prior art keywords
narcotic
composition
analgest
increase
power
Prior art date
Application number
EC2004005153A
Other languages
English (en)
Inventor
Anil Gulati
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of ECSP045153A publication Critical patent/ECSP045153A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Addiction (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones y métodos para el tratamiento del dolor y la reducción o reversión de la tolerancia que los analgésicos de narcóticos están divulgados. La composición y método utiliza un analgésico de narcótico y un antagonista de endotelin como agentes activos para tratar del dolor en los mamíferos, incluyendo los humanos.
EC2004005153A 2001-11-27 2004-06-15 Metodo y composición para aumentar la potencia de un analgésico de narcotico. ECSP045153A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33359901P 2001-11-27 2001-11-27

Publications (1)

Publication Number Publication Date
ECSP045153A true ECSP045153A (es) 2004-08-27

Family

ID=23303472

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005153A ECSP045153A (es) 2001-11-27 2004-06-15 Metodo y composición para aumentar la potencia de un analgésico de narcotico.

Country Status (14)

Country Link
US (3) US7973064B2 (es)
EP (1) EP1448233A2 (es)
JP (1) JP2005513033A (es)
CN (1) CN1646166A (es)
AU (1) AU2002348224A1 (es)
BR (1) BR0214481A (es)
CA (1) CA2464768C (es)
CO (1) CO5590940A2 (es)
EA (1) EA200400734A1 (es)
EC (1) ECSP045153A (es)
MX (1) MXPA04005003A (es)
NO (1) NO20042612L (es)
WO (1) WO2003045434A2 (es)
ZA (1) ZA200403162B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070300258A1 (en) * 2001-01-29 2007-12-27 O'connor Daniel Methods and systems for providing media assets over a network
EP1395289B1 (en) * 2001-06-07 2010-12-15 Christine Dr. Sang Treatment of neuropathic pain with a n-methyl-d-aspartate (nmda) receptor antagonists
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
ES2341922T3 (es) 2001-11-01 2010-06-29 Spectrum Pharmaceuticals, Inc. Composiciones medicas para el tratamiento intravesical de cancer de vejiga.
US8563592B2 (en) 2001-11-01 2013-10-22 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment and methods
US7351692B2 (en) 2002-06-19 2008-04-01 The Board Of Trustees Of The University Of Illinois Method and composition for potentiating the antipyretic action of a nonopioid analgesic
GB0219660D0 (en) 2002-08-23 2002-10-02 Astrazeneca Ab Therapeutic use
AU2003286647B2 (en) 2002-10-24 2009-11-05 The Board Of Trustees Of The University Of Illinois Method and composition for preventing and treating solid tumors
US8026216B2 (en) 2002-10-24 2011-09-27 Spectrum Pharmaceuticals, Inc. Methods and compositions for contributing to the treatment of cancers
US8217010B2 (en) 2002-10-24 2012-07-10 The Board Of Trustees Of The University Of Illinois Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
US20070032422A1 (en) 2002-10-24 2007-02-08 Spectrum Pharmaceuticals, Inc. Methods, compositions and articles of manufacture for contributing to the treatment of cancers
GB0403744D0 (en) 2004-02-20 2004-03-24 Astrazeneca Ab Chemical process
CA2641386A1 (en) * 2005-09-09 2007-03-15 Chicago Labs, Inc. Endothelin receptors in morphine withdrawal
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
KR101547361B1 (ko) 2006-08-31 2015-08-25 스펙트럼 파마슈티컬즈 인크 엔도셀린 효능제 투여를 통한 방사선 요법에 대한 종양 세포의 감작
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
WO2009015917A2 (en) * 2007-05-14 2009-02-05 F. Hoffmann-La Roche Ag Dihydroquinone and dihydronaphthridine inhibitors of jnk
US20090143426A1 (en) * 2007-12-04 2009-06-04 Ralph Anthony Stephani Synthesis of 1,3,6-trisubstituted-2-carboxyquinol-4-ones as selective ET A antagonists and their use as medicaments
JP5498571B2 (ja) * 2009-04-30 2014-05-21 ミッドウェスタン ユニバーシティ センタキンを用いた新規の治療方法
US9308235B2 (en) 2012-05-09 2016-04-12 Spectrum Pharmaceuticals, Inc. Treatment of primary and metastatic carcinoma
JP6928450B2 (ja) 2013-07-08 2021-09-01 ミッドウェスタン ユニバーシティ エンドセリンｂ受容体アゴニストを用いた、神経精神疾患を治療するための組成物及び方法
CN112569238A (zh) * 2019-09-30 2021-03-30 武汉大学 伊马替尼及其衍生物与镇痛药联合用药或复方制剂在治疗疼痛中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
JPH08139146A (ja) * 1994-11-14 1996-05-31 Shin Etsu Handotai Co Ltd 半導体表面のライフタイム評価方法
EP1609477B1 (en) 1994-12-12 2011-11-09 Omeros Corporation Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure
US6673832B1 (en) * 1998-05-04 2004-01-06 Gudarz Davar Methods for identifying compounds for treating pain
CA2409927A1 (en) 2000-05-31 2001-12-06 Warner-Lambert Company Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
WO2002049630A2 (en) * 2000-12-21 2002-06-27 Bristol-Myers Squibb Company Method for preventing or treating pain by administering an endothelin antagonist
US20030232787A1 (en) * 2001-05-08 2003-12-18 Dooley David James Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic

Also Published As

Publication number Publication date
EP1448233A2 (en) 2004-08-25
BR0214481A (pt) 2004-09-14
CA2464768C (en) 2009-12-29
WO2003045434A2 (en) 2003-06-05
US20100113396A1 (en) 2010-05-06
US7973064B2 (en) 2011-07-05
JP2005513033A (ja) 2005-05-12
AU2002348224A1 (en) 2003-06-10
EA200400734A1 (ru) 2004-12-30
US8114896B2 (en) 2012-02-14
NO20042612L (no) 2004-06-22
MXPA04005003A (es) 2004-08-11
ZA200403162B (en) 2005-01-26
CA2464768A1 (en) 2003-06-05
US8410148B2 (en) 2013-04-02
CN1646166A (zh) 2005-07-27
US20100311665A1 (en) 2010-12-09
US20030100507A1 (en) 2003-05-29
WO2003045434A3 (en) 2003-09-25
CO5590940A2 (es) 2005-12-30

Similar Documents

Publication Publication Date Title
ECSP045153A (es) Metodo y composición para aumentar la potencia de un analgésico de narcotico.
ECSP055840A (es) Derivados de 4 -tetrazolil-4fenilpiperidina para el tratamiento del dolor
MXPA05010819A (es) Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
PT1411908E (pt) Tratamento de infeccoes da unha com no
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
ECSP045407A (es) Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf
CY1111177T1 (el) Ενωση φαινοθειαζινιου για επουλωση τραυματων
UY27465A1 (es) Métodos y composiciones para tratar flavivirus y pestivirus con 4' modificaciones nucleosides
MXPA04001876A (es) Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis.
ECSP066575A (es) Antagonistas del receptor b1 de bradiquinina
CU23213A3 (es) Difenilureas sustituidas con omega-carboxiarilo como inhibidores de raf quinasa
BRPI0509420A (pt) método de redução ou inibição da angiogênese e método de aumento da eficácia de tratamento com agente antiangiogênico
ECSP045217A (es) Derivados de n-bifenilmetil aminocicloalcancarboxamida con un sustituyente en el metilo, util como antagonistas de bradicinina
AR044039A1 (es) Combinaciones antineoplasicas
CO5050298A1 (es) Metodo y composicion para tratar impotencia
CY1109031T1 (el) Τριαζασπιρο ενωσεις χρησιμες για την αντιμετωπιση ή προληψη πονου
EP1631267A4 (en) METHOD FOR THE TREATMENT OF DISORDERS WITH HSP90-INHIBITING AGENTS COMBINED WITH ANTIMETABOLITES
DE602006009259D1 (de) Pharmazeutische zusammensetzung mit einem organopoirkstoff
ATE381327T1 (de) Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
AR028772A1 (es) 5-aminoalquil-pirazol[4,3-d] pirimidinas
EA200501166A1 (ru) Составы и способы лечения тромбоцитемии
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
WO2004071413A3 (en) Method and composition for potentiating an opiate analgesic
IS4847A (is) Aðferð til meðferðar gegn hjartabilun þar sem notuð eru mótlyf gegn endóþelíni